We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Incidence of Congenital Undescended Testis Among Dutch Infants

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified May 2008 by Medical Center Alkmaar.
Recruitment status was:  Recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT00264121
First Posted: December 12, 2005
Last Update Posted: May 22, 2008
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Medical Center Alkmaar
  Purpose
The purpose of this study is to determine the incidence of congenital undescended testis of mature boys, at one year of age, born in the Medical Centre Alkmaar (MCA).

Condition
Undescended Testis

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: The Incidence of Congenital Undescended Testis Among Dutch Infants in the Medical Centre Alkmaar

Further study details as provided by Medical Center Alkmaar:

Estimated Enrollment: 3000
Study Start Date: June 2005
Estimated Study Completion Date: June 2008
Detailed Description:
The position of the testes of mature boys will be registered at birth and boys with a high-scrotal, non-scrotal or dubious position of the testis/ testes will be followed up (till the age of one year).
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   up to 1 Year   (Child)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • mature newborns (>/= 37 weeks)
  • born in the Medical Centre Alkmaar

Exclusion Criteria:

  • premature newborns (< 37 weeks)
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00264121


Contacts
Contact: K. Sijstermans, MD +31-72-5482998 k.sijstermans@mca.nl
Contact: W WM Hack, PhD +31-72-5484444 w.hack@mca.nl

Locations
Netherlands
Medical Center Alkmaar (MCA) Recruiting
Alkmaar, Noord-Holland, Netherlands
Contact: K Sijstermans, MD    +31-72-5482998    k.sijstermans@mca.nl   
Sponsors and Collaborators
Medical Center Alkmaar
Investigators
Study Director: W WM Hack, PhD Department of Pediatrics, Medical Centre Alkmaar
  More Information

ClinicalTrials.gov Identifier: NCT00264121     History of Changes
Other Study ID Numbers: P05.0318L
First Submitted: December 9, 2005
First Posted: December 12, 2005
Last Update Posted: May 22, 2008
Last Verified: May 2008

Keywords provided by Medical Center Alkmaar:
congenital, high scrotal

Additional relevant MeSH terms:
Cryptorchidism
Testicular Diseases
Genital Diseases, Male
Urogenital Abnormalities
Congenital Abnormalities
Gonadal Disorders
Endocrine System Diseases